A quadrivalent vaccine against serogroup B meningococcal disease : a cost-effectiveness study

MLA

Christensen, Hannah, et al. A Quadrivalent Vaccine against Serogroup B Meningococcal Disease : A Cost-Effectiveness Study. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn946019666&authtype=sso&custid=ns315887.

APA

Christensen, H., Agnew Emily, Trotter, C., Robays, J., Dubois, C., Devriese, S., Van de Sande, S., Thiry, N., & Hanquet, G. (2014). A quadrivalent vaccine against serogroup B meningococcal disease : a cost-effectiveness study.

Chicago

Christensen, Hannah, Agnew Emily, Caroline Trotter, Jo Robays, Cécile Dubois, Stephan Devriese, Stefaan Van de Sande, Nancy Thiry, and Germaine Hanquet. 2014. “A Quadrivalent Vaccine against Serogroup B Meningococcal Disease : A Cost-Effectiveness Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn946019666&authtype=sso&custid=ns315887.